Loading…
Treatment of Eyebrow Hypotrichosis Using Bimatoprost: A Randomized, Double‐Blind, Vehicle‐Controlled Pilot Study
Background The Food and Drug Administration has approved bimatoprost ophthalmic solution (0.03%) for the treatment of eyelash hypotrichosis. Previous reports of its efficacy in eyebrow hypotrichosis are anecdotal. Objective To assess the efficacy and safety of bimatoprost 0.03% ophthalmic solution a...
Saved in:
Published in: | Dermatologic surgery 2013-07, Vol.39 (7), p.1079-1087 |
---|---|
Main Authors: | , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Background
The Food and Drug Administration has approved bimatoprost ophthalmic solution (0.03%) for the treatment of eyelash hypotrichosis. Previous reports of its efficacy in eyebrow hypotrichosis are anecdotal.
Objective
To assess the efficacy and safety of bimatoprost 0.03% ophthalmic solution applied to the eyebrows in a randomized, double‐blind, vehicle‐controlled study.
Methods
Subjects (n = 20) with mild to moderate eyebrow hypotrichosis enrolled in the study. One group (Bim) applied bimatoprost to each eyebrow daily for 9 months, and another applied vehicle nightly to each eyebrow for 5 months. Subjects in the latter group were re‐randomized to apply bimatoprost (Veh‐Bim Group) or vehicle (Veh Group) daily to each eyebrow for 4 months. The primary end point was investigator‐assessed eyebrow appearance; secondary end points were subject‐reported outcomes.
Results
Investigator assessments showed significant improvements from baseline to 6 (p = .002) and 7 (p = .005) months for the eyebrows treated with bimatoprost. p‐Values for the Veh‐Bim and Veh groups were not significant at any time point. End‐of‐study subject satisfaction with eyebrow fullness or thickness and darkness or color was greater in the Bim group than in the Veh group. Adverse effects were not observed.
Conclusion
Bimatoprost 0.03% ophthalmic solution applied daily for 9 months improves the appearance of eyebrows noticeably more than vehicle, without side effects. |
---|---|
ISSN: | 1076-0512 1524-4725 |
DOI: | 10.1111/dsu.12199 |